Phil Woodward Selected Research

3- (4- (2- hydroxyethyl)piperazin- 1- yl)- 7- (6- methoxypyridin- 3- yl)- 1- (2- propoxyethyl)pyrido(3,4- b)pyrazin- 2(1H)- one

3/2016

Phosphodiesterase-5 Inhibitor PF-03049423 Effect on Stroke Recovery: A Double-Blind, Placebo-Controlled Randomized Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Phil Woodward Research Topics

Disease

1	Ischemic Stroke 03/2016
1	Stroke (Strokes) 03/2016

Drug/Important Bio-Agent (IBA)

1	3- (4- (2- hydroxyethyl)piperazin- 1- yl)- 7- (6- methoxypyridin- 3- yl)- 1- (2- propoxyethyl)pyrido(3,4- b)pyrazin- 2(1H)- oneIBA 03/2016
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 03/2016